Clinical Trials Browser

Denosumab × Sarcoma × Clear all

Osteosarcoma

NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT04798326 2021-03-15

MW032

Phase 1 Completed

120 enrolled

Sarcoma

Bone Neoplasms

Clinical Trials

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

MW032